Golcadomide (BMS-986369)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Golcadomide (BMS-986369), covering 2024-09-27 to 2024-09-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on the Drug Levels of Golcadomide (BMS-986369) in Healthy Participants [Phase 1]